Things Are Changing!

The migration of TuDiabetes has begun

Content created between now and the launch of our new site on April 20th will NOT be moved to that new home, but our community values and Terms of Service still apply during this time.We are not accepting new members during this transition period. If you want to join the TuDiabetes community please send an e-mail to TuDiabetesAdmin@gmail.com. We will send you an invitation to join after the migration is completed.

Read about the migration and see images of the new site!

In germany we have a big problem, insulin analogue should not be paid by health insurance.
Accourding to a opinion of a institut: analogue insulin has no additional benefit as human insulin, therefore they shall not be paid.

To bring this up, we have written a open letter to the secretary of Health.
It is possible to sign the letter, to give more value.

It is a german site but you can use google translate:
Google Translate: http://brief.diabetes-zentrale.de
or
german: http://brief.diabetes-zentrale.de

The sign-function is open until 20-may-2010.

Please help us and sign the letter!
Thank you in advance!


Views: 80

Replies to This Discussion

There is also a petition at the Bundestag (Lower House of German Parliament). But only citizens of Germany are allowed to sign it.
But the sign-period is already over.
What did they say that insulin analogue has no additional benefit as human insulin?
That is the whole argument. Analogues are more expensive and have no additional benefit could justify this.

A Insitut (IQWiG) has human and analogue Insulin compared: the conclusion was they have not enough data -> a additional benifit can't be proved.
The report has more than 200 pages (typical german :D ) but the conclusion is important for the health insurance. But the problem is this institut was founded by those, to reduce the cost.

RSS

Advertisement



REsources

From the Diabetes Hands Foundation blog...

DHF Joins Diabetes Advocacy Alliance

Diabetes Hands Foundation is incredibly honored to join the Diabetes Advocacy Alliance, an organization with the drive and potential to affect a powerful, positive impact on diabetes and healthcare policy. Diabetes Advocacy Alliance is a 20-member coalition of leading professional Read on! →

Helmsley Charitable Trust Renews Support for DHF

HELMSLEY CHARITABLE TRUST GRANTS SUPPORT TO DIABETES HANDS FOUNDATION FOR FOURTH YEAR  Funding in 2015 to support major transitions in programs and leadership at Diabetes Hands Foundation BERKELEY, CA: February 18, 2015 – The Leona M. and Harry B. Helmsley Read on! →

Diabetes Hands Foundation Team

DHF TEAM

Melissa Lee
(Interim Executive Director, Editor, has type 1)


Manny Hernandez
(Co-Founder, has LADA)

Emily Coles (Head of Communities, has type 1)

Mila Ferrer
(EsTuDiabetes Community Manager, mother of a child with type 1)

Mike Lawson
(Head of Experience, has type 1)

Corinna Cornejo
(Director of Operations and Development, has type 2)

Desiree Johnson  (Administrative and Programs Assistant, has type 1)

DHF VOLUNTEERS


Lead Administrator

Brian (bsc) (has type 2)


Administrators

Lorraine (mother of type 1)
Marie B (has type 1)

DanP (has Type 1)

Gary (has type 2)

David (has type 2)

 

LIKE us on Facebook

Spread the word

Loading…

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.

© 2015   A community of people touched by diabetes, run by the Diabetes Hands Foundation.

Badges  |  Contact Us  |  Terms of Service